← Back to headlines
Merck's KEYTRUDA Receives FDA Priority Review for Bladder Cancer
Merck & Co., Inc. (MRK) has been granted FDA Priority Review for its KEYTRUDA regimen in the treatment of muscle-invasive bladder cancer.
23 Apr, 08:40 — 23 Apr, 08:40
Sources
Showing 1 of 1 sources
Related Stories
Philippine Charity Sweepstakes Office Provides ₱18.2M Aid to Mindoro Healthcare
just now
NGO Provides Health Insurance for Pregnant Women in Enugu
just now
Philippines clears irrigation canals in Bicol to mitigate El Niño impact
just now
Kwara State Government Pledges Improved Immunisation Efforts
just now